drugset / Trial / NCT07269808

Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration

NCT07269808

Phase 3 Active not recruiting 100 enrolled Massachusetts General Hospital
RandomizedParallel-groupSingle-blindOther

Summary

This study is a pragmatic, randomized controlled pilot trial comparing remimazolam with propofol for endoscopic procedures, designed to assess the feasibility and clinical outcomes associated with implementing a pragmatic randomized trial of sedation practices in the endoscopy setting.

Timeline

Start
2026-03-03
Primary completion
2026-07-01
Completion
2026-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 1.5 mg/kg
Comparator Propofol Small molecule 10 mg
Comparator Propofol Small molecule 40 mg
Subject Remimazolam Small molecule 0.2 mg/kg

Indications

No indication recorded.